Searchable abstracts of presentations at key conferences in endocrinology

ea0038fp4 | (1) | SFEBES2015

GLP-1 reduces cerebrospinal fluid secretion and intracranial pressure: a novel treatment for idiopathic intracranial hypertension?

Botfield Hannah , Uldall Maria , Mitchell James , Gonzalez Ana Maria , Jensen Rigmor , Sinclair Alexandra

Background: Idiopathic intracranial hypertension (IIH) predominantly affects obese women of childbearing age. IIH is characterised by increased intracranial pressure (ICP) which results in visual loss and disabling headaches. ICP dis-regulation results from imbalance of cerebrospinal fluid (CSF) production rate (at the choroid plexus epithelial cells) and drainage. Treatments for IIH are limited but weight loss is established as disease modifying.Glucago...

ea0050oc3.3 | Obesity, Diabetes Thyroid | SFEBES2017

The GLP-1R agonist exendin-4 reduces cerebrospinal fluid secretion and intracranial pressure

Botfield Hannah , Uldall Maria , Westgate Connar , Mitchell James , Hagen Snorre , Maria Gonzalez Ana , Hodson David , Jensen Rigmor , Sinclair Alexandra

Background: Current therapies for reducing raised intracranial pressure (ICP) in conditions such as idiopathic intracranial hypertension have limited efficacy and tolerability. As such, there is a pressing need to identify novel drugs. Glucagon-like peptide-1 receptor (GLP-1R) agonists are used to treat diabetes and promote weight loss but have also been shown to affect fluid homeostasis in the kidney. Here, we investigate whether exendin-4, a GLP-1R agonist, is able to modula...

ea0050oc3.3 | Obesity, Diabetes Thyroid | SFEBES2017

The GLP-1R agonist exendin-4 reduces cerebrospinal fluid secretion and intracranial pressure

Botfield Hannah , Uldall Maria , Westgate Connar , Mitchell James , Hagen Snorre , Maria Gonzalez Ana , Hodson David , Jensen Rigmor , Sinclair Alexandra

Background: Current therapies for reducing raised intracranial pressure (ICP) in conditions such as idiopathic intracranial hypertension have limited efficacy and tolerability. As such, there is a pressing need to identify novel drugs. Glucagon-like peptide-1 receptor (GLP-1R) agonists are used to treat diabetes and promote weight loss but have also been shown to affect fluid homeostasis in the kidney. Here, we investigate whether exendin-4, a GLP-1R agonist, is able to modula...

ea0084op-10-49 | Oral Session 10: Young Investigators / Clinical and Translational | ETA2022

TSH-receptor antibodies among 1,024 early pregnant women in the north denmark region: cut-off, prevalence, and follow-up

Maria Uldall Torp Nanna , Henrik Bruun Niels , Astrup Christensen Peter , Handberg Aase , Andersen Stig , Linding Andersen Stine

Objectives: Measurement of TSH-receptor antibodies (TRAb) in hyperthyroid, pregnant women is an important tool when distinguishing between the autoimmune GravesÂ’ disease and the physiological gestational hyperthyroidism. Evidence to support a cut-off for TRAb in early pregnancy is needed along with information on the frequency and follow-up of TRAb-positive as opposed to TRAb-negative hyperthyroidism.Methods: Within the North Denmark Region Pregnanc...

ea0092op-06-01 | Oral Session 6: Pregnancy | ETA2023

Antithyroid drug exposure during 1,191,904 pregnancies in denmark: a 20-year longitudinal study before and after implementation of iodine fortification

Maria Uldall Torp Nanna , Liew Zeyan , Carle Allan , Scott Karmisholt Jesper , Bulow Pedersen Inge , Andersen Stig , Linding Andersen Stine

Objectives: Hyperthyroidism in pregnant women is a clinical concern, and it is important to surveil any change in the occurrence of hyperthyroidism within the pregnant population specifically, especially when a mandatory iodine fortification (IF) program is implemented as it was in Denmark in the year 2000. This longitudinal study aimed to investigate any change in the use of antithyroid drugs (ATD) for the treatment of hyperthyroidism in Danish pregnant women during a 20-year...

ea0092ps3-23-01 | Pregnancy | ETA2023

TSH elevation before or after a pregnancy according to unidentified maternal thyroid function and thyroid autoantibody status in the early pregnancy: A study of 13,664 danish pregnant women

Linding Andersen Stine , Hjelm Lundgaard Maja , Maria Uldall Torp Nanna , Lykkeboe Simon , Carle Allan , Karmisholt Jesper , Bulow Pedersen Inge , Vestergaard Peter , Andersen Stig

Objectives: One of the risk-based screening criteria for thyroid disease in pregnancy is previous abnormal thyroid function or thyroid autoantibody-positivity. We speculated on the frequency and results of thyroid function testing in women of fertile age as part of routine care before and after a pregnancy.Methods: The North Denmark Region Pregnancy Cohort includes retrospective assessment of thyroid function and thyroid autoantibodies (ADVIA Centaur XPT...

ea0084op-05-23 | Oral Session 5: Autoimmunity | ETA2022

Cut-offs for thyroid peroxidase and thyroglobulin antibodies in early pregnancy are not similar and may differ from non-pregnant individuals: evidence from 10,905 danish pregnant women

Linding Andersen Stine , Henrik Bruun Niels , Astrup Christensen Peter , Lykkeboe Simon , Handberg Aase , Bo Hansen Annebirthe , Berg Hjelm Maja , Knosgaard Louise , Maria Uldall Torp Nanna , Carle Allan , Scott Karmisholt Jesper , Bulow Pedersen Inge , Vestergaard Peter , Andersen Stig

Objectives: Thyroid disease in women of reproductive age is predominantly of autoimmune origin, and thyroid peroxidase antibodies (TPO-Ab) as well as thyroglobulin antibodies (Tg-Ab) are key markers of autoimmune hypothyroidism. Adding to this, much focus in pregnancy is on euthyroid women who are positive for thyroid autoantibodies. The observational findings are diverse, and evidence to substantiate the applied cut-offs for definition of thyroid autoantibody-positivity in ea...